Anika Therapeutics (ANIK) vs Treace Medical Concepts (TMCI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Anika Therapeutics (ANIK) has outperformed Treace Medical Concepts (TMCI) over the past year, gaining 114.9% versus a loss of 35.2%. Over five years, ANIK leads with a -53.1% price change compared with -84.1% for TMCI. Anika Therapeutics is the larger company by market cap ($257.4 million vs $252.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANIK | TMCI |
|---|---|---|
| Share price | $19.23 | $3.88 |
| Market cap | $257.35M | $252.01M |
| 1-day change | -1.54% | -0.39% |
| YTD return | +103.23% | +58.78% |
| 1-year return | +114.85% | -35.17% |
| 5-year return | -53.12% | -84.07% |
| Forward P/E | 20.24 | — |
| EPS (TTM) | $-0.23 | $-0.92 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $22.88 | $7.08 |
| 52-week low | $8.67 | $1.17 |
| Distance from 52-week high | -15.95% | -45.27% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +19.60% | +41.94% |
| Average volume | 98.57K | 330.27K |
| Shares outstanding | 13.38M | 65.03M |
| Employees | 235 | 450 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ANIK has outperformed TMCI by 150.0 percentage points over the past year.
About Anika Therapeutics
ANIK stock →Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and services, such as Monovisc and Orthovisc, which are single- and multi-injection, HA viscosupplement products indicated for pain relief from OA conditions, as well as Cingal, a non-opioid, single-injection OA pain management product; regenerative solutions, including an HA-based scaffold with bone and tendon fixation components and arthroscopic delivery instruments; Hyalofast, a resorbable scaffold used for single stage cartilage regeneration; and Tactoset injectable bone substitute, an HA-enhanced injectable bone repair therapy designed to treat insufficiency fractures and augment hardware fixation.
Health Care · Medical/Dental Instruments · 235 employees
About Treace Medical Concepts
TMCI stock →Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions.
Health Care · Medical/Dental Instruments · 450 employees
ANIK vs TMCI FAQ
Which is bigger, Anika Therapeutics or Treace Medical Concepts?
Anika Therapeutics (ANIK) is larger, with a market capitalization of $257.35M compared with $252.01M for Treace Medical Concepts (TMCI).
Which stock has performed better over the past year, ANIK or TMCI?
ANIK returned +114.85% over the past 12 months, compared with -35.17% for TMCI (price return, excluding dividends). Past performance does not predict future results.
Are Anika Therapeutics and Treace Medical Concepts in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.